Immune pathogenesis of Mixed Connective Tissue Disease: A short analytical review

Clinical Immunology

Volumn 128, Issue 1, 2008, Pages 8-17

  Hoffman, Robert W ^a,b   Maldonado, Marcos E ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antigen; Apoptosis; Autoantibody; Autoimmune; Mixed Connective Tissue Disease; Pathogenesis; Ribonucleoprotein; Systemic lupus erythematosus; T cell; Toll like receptor

Indexed keywords

ANTIGEN; AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; RIBONUCLEOPROTEIN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME 3; CHROMOSOME 7; CLINICAL FEATURE; GENETIC ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; SHORT SURVEY; SPLICEOSOME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOANTIGENS; HUMANS; MIXED CONNECTIVE TISSUE DISEASE;

EID: 49949152172     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.03.461     Document Type: Short Survey

References (103)

1. Hoffman R.W. Mixed connective tissue disease and overlap syndrome. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus. 7th ed. (2007), Lippincott Williams and Wilkins, New York 975-991
2. Hoffman R.W. Overlap syndromes: mixed connective tissue disease and Sjogren's syndrome. In: Lahita R.G. (Ed). Systemic Lupus Erythematosus. 4th ed. (2004), Elsevier, New York 717-744
3. Hoffman R.W., Rettenmaier L.J., Takeda Y., Hewett J.E., Pettersson I., Nyman U., Luger A.M., and Sharp G.C. Human autoantibodies against the 70-kD polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis. Rheum. 33 (1990) 666-673
4. Sharp G.C., Irvin W.S., Tan E.M., Gould R.G., and Holman H.R. Mixed Connective Tissue Disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52 (1972) 148-159
5. Takano M., Golden S.S., Sharp G.C., and Agris P.F. Molecular relationship between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization. Biochemistry 20 (1981) 5929-5936
6. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA-splicing. Annu. Rev. Biochem. 65 (1996) 367-409
7. Pettersson I., Hinterberger M., Mimori T., Gottlieb E., and Steitz J.A. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J. Biol. Chem. 259 (1984) 5907-5914
8. Peng S.L., and Craft J.L. Spliceosomal snRNPs autoantibodies. In: Peter J.B., and Schoenfeld Y. (Eds). Autoantibodies (1996), Elsevier Science Inc., New York 774-782
9. Holyst M.M., and Hoffman R.W. U-small nuclear ribonucleoprotein (RNP)-reactive autoantibodies: diagnostic testing and clinical interpretation. Clin. immunol. newsl. 18 (1998) 53-57
10. Sharp G.C. MCTD: a concept which stood the test of time. Lupus 11 (2002) 333-339
11. Sullivan W.D., Hurst D.J., Harmon C.E., Esther J.H., Agia G.A., Maltby J.D., Lillard S.B., Held C.N., Wolfe J.F., and Sunderrajan E.V. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 63 (1984) 92-107
12. Burdt M.A., Hoffman R.W., Deutscher S.L., Wang G.S., Johnson J.C., and Sharp G.C. Long-term outcome in mixed connective tissue disease. Longitudinal clinical and serologic findings. Arthritis Rheum. 42 (1999) 899-909
13. Sharp G.C., Irvin W.S., May C.M., Holman H.R., McDuffie F.C., Hess E.V., and Schmid F.R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N. Engl. J. Med. 21 (1976) 1149-1154
14. Sharp G.C. Diagnostic criteria for classification of MCTD. In: Kasukawa R., and Sharp G.C. (Eds). Mixed Connective Tissue Diseases and Anti-Nuclear Antibodies (1987), Elsevier, Amsterdam 23-32
15. Kasukawa R., Too T., Miyawaki S., Yoshida H., Tanimoto K., Nobunaga M., Suzuki T., Takasaki Y., and Tamura T. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R., and Sharp G.C. (Eds). Mixed Connective Tissue Diseases and Anti-Nuclear Antibodies (1987), Elsevier, Amsterdam 41-47
16. Amigues J.M., Cantagrel A., Abbal M., and Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 12 (1996) 2055-2062
17. Doria A., Ghirardello A., de Zambiasi P., Ruffatti A., and Gambari P.F. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J. Rheumatol. 19 (1992) 259-264
18. Alarcon-Segovia D., and Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R., and Sharps G.C. (Eds). Mixed Connective Tissue Diseases and Anti-Nuclear Antibodies (1987), Elsevier, Amsterdam 33-40
19. Alarcon-Segovia D., and Cardiel M.H. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J. Rheumatol. 16 (1989) 328-334
20. Hoffman R.W., Perkins K., and Bezruczko N. Rasch analysis for classification of mixed connective tissue disease (Abstract). Arthritis Rheum. 54 (2006) S149 Suppl.
21. K. Perkins, R.W. Hoffman, N. Bezruczko, A Rasch analysis for classification of systemic lupus erythematosus and mixed connective tissue disease, J. Appl. Meas. 9 (in press).
22. Lundberg I., and Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J. Rheumatol. 23 (1996) 1088-1094
23. Kotajima L., Aotsuka S., Sumiya M., Yokohari R., Tojo T., and Kasukawa R. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J. Rheumatol. 23 (1996) 1088-1094
24. Frandsen P.B., Kriegbaum N.J., Ullman S., Hoier-Madsen M., Wiik A., and Halberg P. Follow up of 151 patients with high-titer U1RNP antibodies. Clin. Rheumatol. 15 (1996) 254-260
25. Nimelstein S.H., Brody S., McShane D., and Holman H.R. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 59 (1980) 239-248
26. Ginsburg W.W., Conn D.L., Bunch T.W., and McDuffie F.C. Comparison of clinical and serological markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients. J. Rheumatol. 10 (1983) 235-241
27. Rosenthal M. Sharp syndrome (mixed connective tissue disease): clinical and laboratory evaluation on 40 patients. Eur. J. Rheumatol. 2 (1979) 237-242
28. Sanders D.Y., Huntley C.C., and Sharp G.C. Mixed connective tissue disease in a child. J. Pediatr. 83 (1973) 642-645
29. Singsen B.H., Swanson V.L., Bernstein B.H., Heuser E.T., Hanson V., and Landing B.H. A histologic evaluation of mixed connective tissue disease in childhood. Am. J. Med. 68 (1980) 710-717
30. Hoffman R.W., Cassidy J.T., Takeda Y., Smith-Jones E.I., Wang G.S., and Sharp G.C. U1-70-kD autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis. Arthritis Rheum. 36 (1993) 1599-1602
31. Maldonado M.E., Perez M., Pignac-Kobinger J., Marx E.T., Tozman E.M., Greidinger E.L., and Hoffman R.W. Clincal and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population. J. Rheumatol. (2008) 1-9 First Release Feb.
32. Weckmann A.L., Granados J., Cardiel M.H., Andrade F., Vargas-Alarcón G., Alcocer-Varela J., and Alarcón-Segovia D. Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population. Clin. Exp. Rheumatol. 17 (1999) 91-94
33. Bodolay E., Csipo I., Gal I., Sipka S., Gyimesi E., Szekanecz Z., and Szegedi G. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin. Exp. Rheumatol. 22 (2004) 409-415
34. Nishimaki T., Aotsuka S., Kondo H., Yamamoto K., Takasaki Y., Sumiya M., and Yokohari R. Immunological analysis of pulmonary hypertension in connective tissue diseases. J. Rheumatol. 26 (1999) 2357-2362
35. Komatireddy G.R., Wang G.S., Sharp G.C., and Hoffman R.W. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J. Rheumatol. 24 (1997) 319-322
36. Keith M.P., Moratz C., Egan R., Zacharia A., Greidinger E.L., Hoffman R.W., and Tsokos G.C. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1-/- mice. Autoimmunity 40 (2007) 208-216
37. Genth E., Zarnowski H., Mierau R., Wohltmann D., and Hartl P.W. HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann. Rheum. Dis. 46 (1987) 189-196
38. Kaneoka H., Hsu K.C., Takeda Y., Sharp G.C., and Hoffman R.W. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kD autoantibody positive connective tissue disease patients. Arthritis Rheum. 35 (1992) 83-94
39. Smolen J.S., and Steiner G. Mixed connective tissue disease: to be or not to be?. Arthritis Rheum. 41 (1998) 768-777
40. Black C.M., Maddison P.J., Welsh K.I., Bernstein R., Woodrow J.C., and Pereira R.S. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum. 31 (1988) 131-134
41. Sharp G.C., and Hoffman R.W. Mixed Connective Tissue Disease. In: Belch J., and Zurier R. (Eds). Connective Tissue Diseases (1995), Chapman & Hall 213-245
42. Hoffman R.W., Sharp G.C., and Deutscher S.L. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum. 38 (1995) 1837-1844
43. Smolen J.S., Klippel J.H., Penner E., Reichlin M., Steinberg A.D., Chused T.M., Scherak O., Graniger W., Hartter E., Zielinski C.C., Wolf A., Davey R.J., Mann D.L., and Mayr W.R. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann. Rheum. Dis. 46 (1987) 457-462
44. Ramos P.S., Kelly J.A., Gray-McGuire C., Bruner G.R., Leiran A.N., Meyer C.M., Namjou B., Espe K.J., Ortmann W.A., Reichlin M., Langefeld C.D., James J.A., Gaffney P.M., Behrens T.W., Harley J.B., and Moser K.L. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun. 7 (2006) 417-432
45. Cervino A.C., Tsinoremas N.F., and Hoffman R.W. A genome-wide study of lupus: preliminary analysis and data release. Ann. N. Y. Acad. Sci. 1110 (2007) 131-139
46. Otsuka J., Horiuchi T., Yoshizawa S., Tsukamoto H., Sawabe T., Kikuchi Y., Himeji D., Koyama T., Mitoma H., Watanabe T., and Harada M. Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: molecular and functional analysis. Arthritis Rheum. 50 (2004) 871-881
47. Mitsiades N., Poulaki V., Mitsiades C.S., Koutras D.A., and Chrousos G.P. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol. Metab. 12 (2001) 384-390
48. Matsumara R., Umemiya K., Kagami M., Tomioka H., Tanabe E., Sugiyama T., Sueishi M., Kayagaki N., Yagita H., and Okumura K. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjogren's syndrome. Clin. Exp. Rheumatol. 20 (2002) 791-798
49. Tsai H.F., Lai J.J., Chou A.H., Wang T.F., Wu C.S., and Hsu P.N. Induction of costimulation of human CD4T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 629-639
50. Lub-de Hooge M.N., de Vries E.G., de Jong S., and Bijl M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 854-858
51. Ohno H. Pathogenic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma. Histol. Histopathol. 19 (2004) 637-650
52. Kastner B., Kornstädt U., Bach M., and Lührmann R. Structure of the small nuclear RNP particle U1: identification of the two structural protuberances with RNP-antigens A and 70K. J. Cell Biol. 116 (1992) 839-849
53. Casiola-Rosen L., Miller D.K., Anhalt G.J., and Rosen A. Specific cleavage of the 70-kDa protein component of the U1-70kDa small nuclear ribonucloeprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269 (1994) 30757-30760
54. Casciola-Rosen L.A., Anhalt G., and Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179 (1994) 1317-1330
55. Hall J.C., Casiola-Rosen L., and Rosen A. Altered structure of autoantigens during apoptosis. Rheum. Dis. Clin. North Am. 30 (2004) 455-471
56. Hof D., Raats J.M.H., and Pruijin G.J.M. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen. Autoimmun. Rev. 4 (2005) 380-388
57. Greidinger E.L., Foecking M.F., Ranatunga S., and Hoffman R.W. Apoptotic U1-70-kD is antigenically distinct from the intact form of the U1-70-kD molecule. Arthitis Rheum. 46 (2002) 1264-1269
58. Hoff D., Cheung K., de Rooij D.J.R., van den Hoogen F.H., Prujin G.J.M., and van Venrooij W.J. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res. Ther. 7 (2005) 302-309
59. Greidinger E.L., Casiola-Rosen L., Morris S.M., Hoffman R.W., and Rosen A. Autoantibody recognition of distinctly modified forms of the U1-70-kD antigen is associated with different clinical disease manifestations. Arthritis Rheum. 43 (2000) 881-888
60. Murakami A., Kojima K., Ohya K., Imamura K., and Takasaki Y. A new conformational epitope generated by the binding of recombinant 70-kD protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease. Arthritis Rheum. 46 (2002) 3273-3282
61. Christensen S.R., and Shlomchik M.J. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin. Immunol. 19 (2007) 11-23
62. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823-835
63. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
64. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 595-598
65. Hoffman R.W., Gazitt T., Foecking M.F., Ortman R.A., Misfeldt M., Jorgenson R., Young S.L., and Greidinger E.L. U1 RNA induces innate immunity signaling. Arthritis Rheum. 50 (2004) 2891-2896
66. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R., Mamula M.J., Christensen S.R., Shlomchik M.J., Viglianti G.A., Rifkin I.R., and Marshak-Rothstein A. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202 (2005) 1171-1177
67. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R., and Shlomchik M.J. Toll-like receptor 7 and Toll-like receptor 9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006) 417-428
68. Greidinger E.L. Immune effects of autoantigen-associated RNA. Adv. Exp. Med. Biol. 598 (2007) 293-308
69. Rifkin I.R., Leadbetter E.A., Busconi L., Viglianti G., and Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204 (2005) 27-42
70. Greidinger E.L., and Hoffman R.W. Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 (2005) 437-450
71. Maddison P.J., and Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 20 (1977) 819-824
72. Monneaux F., and Muller S. Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins. Arthritis Rheum. 54 (2001) 45-54
73. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., and Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003) 1499-1500
74. Greidinger E.L., and Hoffman R.W. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kD and B′/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 44 (2001) 368-375
75. Hoet R.M., Koornneef I., de Rooij D.J., van de Putte L.B., and van Venrooij W.J. Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 35 (1992) 1202-1210
76. Ikeda K., Takasaki Y., Hirokawa K., Takeuchi K., and Hashimoto H. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. J. Rheumatol. 30 (2003) 998-1005
77. Datta S.K., Zhang L., and Xu L. T-helper cell intrinsic defectin lupus that break peripheral tolerance to nuclear autoantigens. J. Mol. Med. 83 (2005) 267-278
78. Datta S.K. Major peptide autoepitopes for nucleosome-centered T and B cell interactions in human and murine lupus. Ann. N.Y. Acad. Sci. 987 (2003) 79-90
79. Baumgart D.C., and Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 369 (2007) 1627-1640
80. Chen W., Bluestone J.A., and Herold K.C. Acheiveing antigen-specific tolerance in diabetes: regulating specifically. Int. Rev. Immunol. 24 (2005) 287-305
81. Hoffman R.W. T cells in the pathogenesis of systemic lupus erythematosus. Clin. Immunol. 113 (2004) 4-13
82. Greidinger E.L., Gazitt T., Jaimes K.F., and Hoffman R.W. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients provide help for autoantibody production. Arthritis Rheum. 50 (2004) 2216-2222
83. O'Brien R.M., Cram D.S., Coppel R.L., and Harrison L.C. T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders. J. autoimmun. 3 (1990) 747-757
84. Hoffman R.W., Takeda Y., Sharp G.C., Lee D.R., Kaneoka K., and Caldwell C.W. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151 (1993) 6460-6469
85. Okubo M., Yammamoto K., Kato T., Matsuura N., Nishimaki T., Kasukawa R., Ito K., Mizushima Y., and Nishioka K. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J. Immunol. 151 (1993) 1108-1115
86. Holyst M.M., Hill D.L., Hoch S.O., and Hoffman R.W. Analysis of human T cell and B cell responses against U-small nuclear ribonucleoprotein 70-kD, B and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum. 40 (1997) 1493-1503
87. Steiner G., Skiner K., and Smolen J.S. Autoantibodies to the A/B proteins of the heterogenous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases. Int. Arch. Allergy Immunol. 111 (1996) 314-319
88. Greidinger E.L., Foecking M.F., Schafermeyer K.R., Bailey C.W., Primm S.L., Lee D.R., and Hoffman R.W. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J. Immunol. 169 (2002) 3429-3437
89. Talken B.L., Lee D.R., Caldwell C.W., Quinn T.P., Schafermeyer K.R., and Hoffman R.W. Analysis of T cell receptors specific for U1-70kD small nuclear ribonucleoprotein autoantigen: the alpha chain complementarity determining region three is highly conserved among connective tissue disease patients. Human Immunol. 60 (1999) 200-208
90. Greidinger E.L., Zang Y., Jaimes K., Hogenmiller S., Nassiri M., Bejarano P., Barber G.N., and Hoffman R.W. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 54 (2006) 661-669
91. E.L. Greidinger, Y. Zang, K. Jaimes, M. Nassiri, R.W. Hoffman, U1-70kD ribonucleoprotein RNA binding domain autoantigen-specific CD4+ T cells have a central role in disease pathogenesis in HLA-DR4 transgenic murine model of mixed connective tissue disease, J. Immunol. (in press).
92. Liossis S.N., Hoffman R.W., and Tsokos G.C. Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone. Clin. Immunol. Immunopathol. 88 (1998) 305-310
93. Crespo S., Maldonado M., Triana E., Pignac-Kobinger J., Perez M., Slusher J., Greidinger E.L., and Hoffman R.W. Expansion of perforin/granzyme-B+ CD8+ T cells expressing activation markers correlates with disease activity in systemic lupus erythematosus and mixed connective tissue disease. (Abstract). Arthritis Rheum. 56 (2007) S549 Suppl.
94. Couzi L., Merville P., Deminière C., Moreau J.F., Combe C., Pellegrin J.L., Viallard J.F., and Blanco P. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum. 56 (2007) 2362-2370
95. Blanco P., Pitard V., Viallard J.F., Taupin J.L., Pellegrin J.L., and Moreau J.F. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 201-211
96. Crispin J.C., Martinez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21 (2003) 273-276
97. Liu M.F., Wang C.R., Fung L.L., and Wu C.R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 59 (2004) 198-202
98. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debré P., Piette J.C., and Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175 (2005) 8392-8400
99. Valencia X., Yarboro C., Illei G., and Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178 (2007) 2579-2588
100. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., Akira S., Kelly K.M., Reeves W.H., Bauer S., and Krieg A.M. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202 (2005) 1575-1585
101. Jurk M., Kritzler A., Schulte B., Tluk S., Schetter C., Krieg A.M., and Vollmer J. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides. Eur. J. Immunol. 36 (2006) 1815-1826
102. Rayner C.F., and Grubnic S. Pulmonary manifestations of systemic autoimmune disease. Best Pract. Res. Clin. Rheumatol. 18 (2004) 381-410
103. Magliano M., Isenberg D.A., and Hillson J. Pulmonary hypertension in autoimmune rheumatic diseases: where are we now?. Arthritis Rheum. 46 (2002) 1997-2009